Log In
BCIQ
Print this Print this
 

Apo805K1

  Manage Alerts
Collapse Summary General Information
Company Apotex Inc.
DescriptionSynthetic hemoregulatory dipeptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationPsoriasis
Indication DetailsTreat chronic plaque psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today